How to read a patent portfolio: a guide for investors and M&A professionals
The most common mistake in patent portfolio evaluation is treating headcount as a proxy for strength. A company with 100 patents is not necessarily better protected than one with five. What matters is structure — which technology areas are covered, by which patent types, and how those patents interact with the core product.
This guide gives investors and M&A professionals three frameworks for evaluating a patent portfolio before engaging IP counsel. A first-pass assessment is well within reach using freely available tools like J-PlatPat and Google Patents. For the steps that follow — legal validity, freedom-to-operate analysis, and contract review — see the IP due diligence workflow for technical teams.
How patents work: from filing to expiry
The core bargain
A patent grants its holder an exclusive right to practice an invention for up to 20 years from the filing date, in exchange for public disclosure of that invention. The system’s logic is explicit: the state trades a time-limited monopoly for knowledge that eventually enters the public domain.
For investment purposes, the key insight is that a patent is not just a legal instrument — it is a signal about the durability of a competitive advantage.
The stages between filing and expiry
Understanding where a patent sits in its lifecycle matters for interpreting “we have X patents” claims in pitch decks and IR materials.
| Stage | What happens | What it means for your assessment |
|---|---|---|
| Filing | Inventor submits the application to the patent office | Signals R&D intent and direction; no legal rights yet |
| Publication (18 months after filing) | Application becomes publicly visible | Competitors can now read the technical disclosure |
| Examination | The examiner assesses novelty, inventive step, and industrial applicability | Scope can narrow or widen depending on how the applicant responds to office actions |
| Registration / grant | Patent is issued; exclusive rights begin | The only stage where legally enforceable rights exist |
| Maintenance | Annual fees keep the patent in force | Failure to pay results in lapse; maintained patents signal continued strategic interest |
Grant rates vary widely — from around 20% to 70% depending on the technology area and jurisdiction. A large filing portfolio with a low grant rate warrants a question: is the company filing strategically, or accumulating applications without rigorous prosecution?
Measuring portfolio strength on three axes
Axis 1: Volume and grant rate
- Filing count vs. grant count: The ratio matters more than either number in isolation
- Grant rate (grants ÷ filings): High rates suggest high-quality inventions, but deliberately letting applications lapse to force disclosure (preventing competitors from patenting the same idea) is also a legitimate strategy
- Year-over-year filing trends: A rising trend signals increased R&D investment; a sudden drop may indicate budget cuts or a strategic pivot away from IP protection
Axis 2: Quality (citation count and claim breadth)
- Forward citations: The number of times a patent is cited by subsequent patents is a rough proxy for foundational importance. LENS.org and Google Patents both surface this data at no cost
- Independent claim breadth: A claim is the legal boundary of what a patent protects. Independent claims (those that stand alone, not by reference to another claim) with fewer elements are broader — and harder for competitors to design around. More elements means a narrower, more easily circumvented right
Axis 3: Geographic coverage
Patent rights are territorial. A Japanese patent offers no protection in the US market, and vice versa.
| Jurisdiction | Strategic significance |
|---|---|
| Japan (J-PlatPat) | Home-market protection baseline |
| United States (USPTO) | Central to global litigation strategy |
| Europe (EPO) | Unified filing covers major EU markets |
| China (CNIPA) | Protection against manufacturing-based copying |
When a startup pursuing global expansion holds patents only in its home market, the gap between stated ambition and actual IP coverage is a material risk. Ask whether PCT (Patent Cooperation Treaty) applications have been filed and which national phases are planned.
Defensive, offensive, and blocking patents
Portfolio structure reveals IP strategy. Most portfolios contain a mix of three types, each with a distinct purpose.
Defensive patents cover the company’s own products and services. Beyond direct protection, they create negotiating leverage: when a competitor asserts infringement, a defensive portfolio allows a counterclaim, often leading to a cross-licensing agreement rather than costly litigation. The absence of defensive coverage around a core product is a material risk.
Offensive patents are filed with the intent to assert them against competitors — through licensing demands, litigation, or injunctions that force market withdrawal. In global technology markets, an offensive portfolio can function as a market entry barrier. Be aware that patent non-practicing entities (NPEs, commonly called patent trolls) deploy offensive portfolios as a primary business model; holdings of that type in a target company’s sector are also a liability risk.
Blocking patents target technology pathways that competitors would need to traverse to build a competing product. By patenting unavoidable implementation methods, a company can make the cost of independent development prohibitively high. This type is especially potent in fast-moving fields like AI and advanced materials, where a few well-placed filings can foreclose entire approaches.
A portfolio composed entirely of defensive patents reflects a protect-what-we-have posture. One that includes offensive and blocking patents signals an active, forward-looking IP strategy — though it also raises questions about resource allocation and litigation risk.
A practical reading workflow for non-engineers
Step 1: Get the lay of the land
Search the target company by name on Google Patents (use the “Assignee” filter) or J-PlatPat for Japan-specific filings. Note the total filing count, grant count, year-over-year trend, and the names of primary inventors — then cross-reference those names against the current employee roster.
Step 2: Map the technology landscape
Read only titles and abstracts for five to ten patents. The goal is not technical depth but a rough map: which product areas are covered, and how closely do those areas track the company’s stated competitive advantages? A mismatch — patents concentrated in areas outside the core product — warrants scrutiny.
Step 3: Read one independent claim
For each patent you examine, read Claim 1. This is the broadest independent claim and defines the outer boundary of protection. A claim with fewer elements covers more ground and is harder to design around; a claim with many specific elements is easier to circumvent through minor variation.
You do not need to reach a legal conclusion. The question to hold in mind is: does this claim cover what the company says it covers?
Step 4: Check maintenance and ownership
- Maintenance fees: Lapsed fees end the patent’s enforceability. In J-PlatPat, the “prosecution history” tab shows payment status. A strategic patent that has lapsed is worth investigating
- Registered owner: Confirm the legal entity matches the current corporate structure, especially post-merger or post-reorganization
- Inventor assignment: Patents developed by contractors or former employees require valid assignment agreements. Missing assignments are a common finding in IP due diligence
The broader context for these checks — how IP assessment fits within a full technical due diligence — is covered in the seven axes of technical due diligence.
Three questions for your investment checklist
After completing the steps above, evaluate the portfolio against these three questions.
1. Are the core product’s key features covered by granted (not merely filed) patents?
Pending applications carry no enforceable rights. If the competitive differentiators are protected only by pending applications, the degree of actual IP protection is substantially lower than the filing count implies.
2. Can management articulate the intent behind the portfolio?
“We have fifty patents” is a data point. “We focus on blocking the two most efficient inference pathways in our domain while maintaining defensive coverage on our inference engine” is IP strategy. Ask for the latter. Inability to explain the portfolio’s logic often signals that IP is being accumulated reactively rather than managed purposefully.
3. Does geographic coverage match the go-to-market plan?
A company planning US or EU expansion with only domestic patents is operating with a structural gap between ambition and protection. Ask specifically about PCT applications and which national phase entries are planned — and by when.
These three questions serve as triage, not verdict. They identify where to direct IP counsel’s attention rather than replacing the specialist review. For full IP due diligence — FTO analysis, contract review, and trade secret assessment — engage a qualified patent attorney. For investment due diligence support on technical and IP matters, see TiedPro for investors.